Elvis Oeb

This review is from a real person who provided valid contact information and hasn't been caught misusing, spamming or abusing our website. Check our FAQ

Verified Reviewer
| map-marker Branchburg, New Jersey

Summit Nutritionals International Defeats Sioux Pharm, Inc. In Legal Battle

stars-rating-full stars-rating-full stars-rating-full stars-rating-full stars-rating-full
Summit Nutritionals International Defeats Sioux Pharm, Inc. In Legal Battle
Summit Nutritionals International Defeats Sioux Pharm, Inc. In Legal Battle - Image 2

Summit Nutritionals International, Inc of New Jersey is victorious in their legal battle against Sioux Pharm, Inc of Sioux Center, Iowa. As of October 2, 2015, Dr. Allan Kramer, President of Sioux Pharm, Inc, has formally withdrawn all claims made against Summit Nutritionals International in Case No. LACV 023704 in the Distict Court in and for Woodbury County, Iowa.

In addition, Sioux Pharm retracts all allegations made against Summit Nutritionals International.

For more information regarding the recent victory of Summit Nutritionals against Sioux Pharm, please visit the following links.

https://youtu.be/3s2_LdrkHzE

https://www.youtube.com/watch?v=HiNmCtBkvOc

https://drive.google.com/open?id=0Bw_vbILKB2esbXRYMnJfT0dQOTA

http://summitnutritionals.com/sioux-pharm-inc-withdrawal-of-claims-and-retraction-of-allegations-against-summit-nutritionals-international-inc/

http://summitnutritionals.net/sioux-pharm-inc-withdrawal-of-claims-and-retraction-of-allegations-against-summit-nutritionals-international-inc/

http://americanchondroitin.com/sioux-pharm-inc-withdrawal-of-claims-and-retraction-of-allegations-against-summit-nutritionals-international-inc/

http://usachondroitin.com/sioux-pharm-inc-withdrawal-of-claims-and-retraction-of-allegations-against-summit-nutritionals-international-inc/

http://summitnutritionalsinc.com/sioux-pharm-inc-withdrawal-of-claims-and-retraction-of-allegations-against-summit-nutritionals-international-inc/

http://droi-kon.com/sioux-pharm-inc-withdrawal-of-claims-and-retraction-of-allegations-against-summit-nutritionals-international-inc/

http://sioux-pharm-inc-and-sioux-pharm-biochemical.pissedconsumer.com/summit-nutritionals-vs-sioux-pharm-inc-withdrawal-of-claims-and-retraction-of-allegations-201510****3890.html

http://www.scam.com/showthread.php?685246-Summit-Nutritionals-International-vs-Sioux-Pharm-Inc-Withdrawal-of-Claims-and-Retraction-of-Allegations&p=188****#post188****

https://summitnutritionals.wordpress.com

View full review
Reason of review:
Frivolous Lawsuit

Preferred solution: Let the company propose a solution

Elvis Oeb

This review is from a real person who provided valid contact information and hasn't been caught misusing, spamming or abusing our website. Check our FAQ

Verified Reviewer

Summit Nutritionals vs. Sioux Pharm, Inc. - Sioux Center, Iowa

stars-rating-full stars-rating-full stars-rating-full stars-rating-full stars-rating-full

Exmo. Senhor Juiz

do Tribunal da Comarca de Lisboa

SUMMIT NUTRITIONALS INTERNATIONAL INC., sucursal em Portugal, com

o NPC 98041****, com domicilio em Lisboa, no Empreendimento Nova

Amoreiras – Palácio- 3ºpiso, secção 9, Rua Artilharia Um, 71-77, 125*-038

Lisboa, Portugal,

Vem requerer contra,

SIOUX PHARM INC., sociedade comercial norte americana com sede em

121 19th Street SW

Sioux Center, IA 51250, Iowa, Estados Unidos da América,

PROVIDÊNCIA CAUTELAR NÃO ESPECIFICADA, nos termos e com os

fundamentos seguintes:

1

A Reqte, SUMMIT NUTRITIONALS INTERNATIONAL INC., é uma sociedade comercial, com sede em New

Jersey, EUA, que, através da sua sucursal em Portugal, se dedica à comercialização, nos países da União

Europeia, de sulfato de condroitina, sob a marca DROI-KON, que importa dos EUA.

2

O produto comercializado pela Reqte, SUMMIT NUTRITIONALS INTERNATIONAL INC., é sulfato de condroitina

do grau alimentar, em que é requisito de pureza que tenha um teor de sulfato de condroitina em percentagem

não inferior a 90%, existindo também no mercado o sulfato de condroitina do grau farmacêutico que, além do

mesmo teor mínimo de sulfato de condroitina, deve ainda satisfazer determinados requisitos da USP

(Farmacopeia dos E.U.A.), conforme se elucida na informação de que se junta cópia como doc. nº1 e aqui se dá

por reproduzida.

3

A Reqte., SUMMIT NUTRITIONALS INTERNATIONAL INC., adquire habitualmente o produto que comercializa

ao fabricante EAGLE LABORATORIES INC., cuja fábrica se situa no Estado de IOWA nos E.U.A.

4

A Reqda., SIOUX PHARM INC., é uma sociedade comercial com sede no dito Estado de IOWA, que se dedica à

fabricação e comercialização de sulfato de condroitina de grau farmacêutico, sob a marca CHONDROPURE,

entre outros produtos.

5

O sulfato de condroitina do grau alimentar é comercializado na Europa por um preço entre vinte e trinta Euro por

kilo, enquanto o preço do de grau farmacêutico excede os cem Euro por kilo.

6

O produto comercializado pela Reqte. SUMMIT NUTRITIONALS INTERNATIONAL INC., é por esta submetido a

análises em laboratórios acreditados pela FDA - Food and Drug Administration dos E.U.A. (o seu próprio

laboratório e 4 laboratórios independentes), tendo sempre tais análises evidenciado a existência nas amostras

de, pelo menos, 90% de sulfato de condroitina, ou seja, o grau de pureza exigido para o produto. Juntam-se,

como exemplos, certificado de análises e relatórios das 5 análises referidas nesse certificado, como docs. nºs. 2

a 7, que aqui se dão por reproduzidos.

7

Os clientes da Reqte., SUMMIT NUTRITIONALS INTERNATIONAL INC., que, na Europa, são mais de duas

dezenas, procedem também a análises de amostras do produto fornecido pela Reqte., SUMMIT NUTRITIONALS

INTERNATIONAL INC., em laboratórios de sua escolha, e até à presente data não apresentaram qualquer

reclamação por falta de pureza do produto, antes se manifestaram sempre inteiramente satisfeitos com a

qualidade do produto fornecido pela Reqte., SUMMIT NUTRITIONALS INTERNATIONAL INC.

8

Importa relevar que a Reqte., SUMMIT NUTRITIONALS INTERNATIONAL, INC., obteve do muito exigente

Better Business Bureau Serving New Jersey a acreditação como empresa que adopta práticas de negócio

conformes com a ética na publicidade, nas vendas e nas relações com os clientes, como resulta do certificado

de que se junta cópia como doc. nº 8 e aqui se dá por reproduzido.

9

Importa referir que os métodos de análise adequados ao produto de grau alimentar são diferentes dos

adequados ao produto de grau farmacêutico, podendo estes últimos, se usados em análises de amostras de

produto do grau alimentar, conduzir a resultados de pureza inferior à exigida.

10

No âmbito de uma disputa industrial e comercial com a referida fornecedora da Reqte., SUMMIT

NUTRITIONALS INTERNATIONAL INC., a Reqda., SIOUX PHARM INC., instaurou no Tribunal de IOWA uma

acção em que denuncia actos de espionagem industrial e de adulteração do sulfato de condroitina por adição de

maltodextrina, cometidos pela EAGLE LABORATORIES INC.

11

Em termos manifestamente abusivos, uma vez que a Reqte., SUMMIT NUTRITIONALS INTERNATIONAL INC.,

como a Reqda., SIOUX PHARM INC., perfeitamente sabe, não é fabricante e se limita a comercializar o produto

que adquire a fabricantes, a Reqda., SIOUX PHARM INC., alega nessa acção que também a Reqte., SUMMIT

NUTRITIONALS INTERNATIONAL INC., e uma outra empresa Cliente da Eagle Laboratories procederiam à

referida diluição do sulfato de condroitina com maltodextrina.

12

A Reqte., SUMMIT NUTRITIONALS INTERNATIONAL INC., não tem razões para admitir que a sua fornecedora

EAGLE LABORATORIES INC. proceda a adulterações do produto, mas pode assegurar que, ainda que tenha

tais comportamentos, não existe qualquer adulteração no produto que é fornecido à Reqte., SUMMIT

NUTRITIONALS INTERNATIONAL INC., como resulta das análises a que, sistematicamente, tanto a Reqte.,

SUMMIT NUTRITIONALS INTERNATIONAL INC., como os seus clientes, procedem.

13

No falso pressuposto de que a Reqte., SUMMIT NUTRITIONALS INTERNATIONAL INC., comercializa o produto

adulterado, para mais contribuindo para tal adulteração, a Reqda., SIOUX PHARM INC., acusa a Reqte.,

SUMMIT NUTRITIONALS INTERNATIONAL INC., da inerente concorrência desleal e pede que a Reqte,

SUMMIT NUTRITIONALS INTERNATIONAL INC., seja condenada no pagamento de indemnização dos danos

sofridos pela Reqda., SIOUX PHARM INC., que não especifica nem quantifica, bem como que seja intimada a

não diluir e a não distribuir ou vender sulfato de condroitina diluído e, em manifesto excesso face aos factos

alegados, que a Reqte., SUMMIT NUTRITIONALS INTERNATIONAL INC., tenha a sua actividade concorrente

com a da Reqda., SIOUX PHARM INC., paralisada ou suspensa durante, no mínimo, a pendência da acção.

14

Este último pedido da Reqda., SIOUX PHARM INC., serve bem a ilustrar o seu objectivo real de aceder a uma

posição monopolista ou quase monopolista no mercado do produto em causa, reduzido ao de grau farmacêutico,

que um pedido que fosse meramente corolário dos factos alegados, ou seja, o da intimação da Reqte, SUMMIT

NUTRITIONALS INTERNATIONAL INC., à não comercialização de produto adulterado, não lhe permitiria

alcançar.

15

Tendo em conta que a Reqda, SIOUX PHARM INC., comercializa também o seu produto na U.E., a Reqte.,

SUMMIT NUTRITIONALS INTERNATIONAL INC., receia fundadamente que a Reqda., SIOUX PHARM INC.,

que igualmente tem Clientes nesse mercado, em comportamentos de concorrência contrários às normas e usos

honestos de qualquer ramo da actividade económica, tente também perturbar a actividade da sucursal em

Portugal da Reqte., SUMMIT NUTRITIONALS INTERNATIONAL INC., seja através de falsas afirmações com o

fim de a desacreditar, seja através de falsas descrições sobre a qualidade do produto comercializado pela Reqte.

SUMMIT NUTRITIONALS INTERNATIONAL INC..

16

Tendo em conta a grande diferença de preço entre o produto comercializado pela Reqda., SIOUX PHARM INC.,

e o produto comercializado pela Reqte., SUMMIT NUTRITIONALS INTERNATIONAL INC., bem se compreende

o interesse da Reqda., SIOUX PHARM INC., em desacreditar ou mesmo eliminar do mercado empresas que

fornecem um segmento do mercado com produto de preço muito mais baixo, cujos clientes só recorrerão à

compra do produto, de grau farmacêutico, da Reqda., SIOUX PHARM INC., quando estiverem em causa

utilizações ou exigências dos clientes finais que não possam de todo ser satisfeitas com o produto de grau

alimentar.

17

Mas a Reqda., SIOUX PHARM INC., não se fica por estes comportamentos de concorrência desleal, que já usou

na acção instaurada no IOWA, antes, na sua ganância, trata também de adulterar o seu próprio produto,

procurando assim aumentar os seus ganhos também por redução dos custos de fabrico.

18

A adulteração do produto da Reqda., SIOUX PHARM INC., que só a esta pode imputar-se, pôde ser constatada

pela Reqte. SUMMIT NUTRITIONALS INTERNATIONAL INC., através da análise do conteúdo de uma

embalagem perfeitamente identificada como de Chondropure, fornecido pela Reqda., SIOUX PHARM INC.

19

Essa embalagem, tal como foi fornecida pela Reqda., SIOUX PHARM INC., a uma empresa que é também

Cliente da Reqte. SUMMIT NUTRITIONALS INTERNATIONAL INC., do produto de grau alimentar, foi colocada

por essa empresa à disposição da Reqte., SUMMIT NUTRITIONALS INTERNATIONAL INC., para análise.

20

Da análise, efectuada por um laboratório independente aprovado pela FDA, resultou que o produto fornecido

pela Reqda., SIOUX PHARM INC., nem sequer satisfaz os requisitos do grau alimentar, pois apresenta um teor

de sulfato de condroitina de apenas 24,90%, não satisfazendo igualmente outros requisitos do grau

farmacêutico, como resulta do relatório da análise datado de 4.3.2015 e da identificação da amostra analisada,

que se juntam como docs. nºs. 9 e 10 e aqui se dão por reproduzidos.

21

Ao comercializar o produto com tais desconformidades em relação às características que deveria ter em

correspondência com as expectativas dos Clientes e com o anunciado pela Reqda., SIOUX PHARM INC., esta

incorre, também por isso, em concorrência desleal, por falsa descrição ou indicação sobre a qualidade e a

utilidade do produto.

22

A Reqte., SUMMIT NUTRITIONALS INTERNATIONAL INC., tem o direito de exercer a sua actividade económica

lícita e transparente, no mercado Europeu, em leal concorrência com outros operadores nesse mercado e

protegida de perturbações causadas por operadores que actuem ao arrepio das honestas práticas dessa

actividade.

23

Os comportamentos estigmatizados da Reqda., SIOUX PHARM INC., fazem recear a Reqte. SUMMIT

NUTRITIONALS INTERNATIONAL INC., que aquela venha a utilizá-los para interferir e perturbar ilicitamente a

sua actividade no mercado Europeu.

24

Este receio da Reqte., SUMMIT NUTRITIONALS INTERNATIONAL INC., encontra sólido fundamento naqueles

comportamentos da Reqda., SIOUX PHARM INC., e é de molde a justificar plenamente as providências

concretamente adequadas a assegurar a efectividade do direito ameaçado da Reqte, SUMMIT NUTRITIONALS

INTERNATIONAL INC..

25

Tais providências são, neste caso, a intimação da Reqda., SIOUX PHARM INC., para que se abstenha de toda e

qualquer afirmação susceptível de desacreditar a Reqte., SUMMIT NUTRITIONALS INTERNATIONAL INC., e o

seu produto e, bem assim, se abstenha de introduzir no mercado Europeu sulfato de condroitina que não

satisfaça inteiramente o requisito de pureza de um teor de, pelo menos, 90% deste produto e, tratando-se de

sulfato de condroitina do grau farmacêutico, que não satisfaça os demais requisitos exigidos para esse grau do

produto.

26

O risco de lesão que se pretende acautelar é o de a Reqda., SIOUX PHARM INC., vir a causar dano irreparável

ou de muito difícil reparação à Reqte., SUMMIT NUTRITIONALS INTERNATIONAL INC., por afectação da sua

reputação de honestidade, e ao seu produto, por dúvidas sobre a sua pureza, com inevitáveis reflexos junto da

clientela da Reqte., SUMMIT NUTRITIONALS INTERNATIONAL INC., susceptível de conduzir a uma drástica

redução do seu nível de vendas com substituição por concorrentes que, posteriormente, será muito difícil, se não

impossível, desalojar.

27

Tal risco não é especialmente prevenido por nenhuma das providências legalmente tipificadas.

28

Cumpre ainda mencionar que, face ao previsível comportamento da Reqda., SIOUX PHARM INC., o não

decretamento da presente providência cautelar importará para a ora Reqte., SUMMIT NUTRITIONALS

INTERNATIONAL INC., que sempre tem pautado o seu comportamento pela transparência, rigor e cumprimento

das normas e usos honestos do ramo da actividade económica em que se insere, incomensuráveis prejuízos,

potenciando a redução do seu nível de vendas e prejudicando a sua credibilidade no mercado.

29

Por outro lado, do decretamento da providência requerida, que não será mais do que exigir da Reqda., SIOUX PHARM INC.,

que actue de acordo com as honestas práticas da actividade exercida, designadamente abstendose

de adulterar o produto comercializado, nenhum prejuízo poderá obviamente resultar para a Reqda., SIOUX PHARM INC..

Nestes termos e nos mais de direito aplicáveis,

deverá a Reqda., SIOUX PHARM INC., ser

intimada para que se abstenha de toda e qualquer

afirmação susceptível de desacreditar a Reqte.,

SUMMIT NUTRITIONALS INTERNATIONAL INC.

e o seu produto e, bem assim, se abstenha de

introduzir no mercado Europeu Sulfato de

condroitina que não satisfaça inteiramente o

requisito de pureza de um teor de, pelo menos,

90% deste produto e, tratando-se de sulfato de

condroitina do grau farmacêutico, que não

satisfaça os demais requisitos exigidos para esse

grau do produto.

Para tanto, requer a V. Exa. mande proceder à

citação da Reqda., nos termos da Convenção de

Haia de 15 de Novembro de 1965 (formulário

junto), para, querendo, deduzir oposição, no prazo

e sob a cominação legal, seguindo-se o demais

termos até final.

Esta providência é requerida como preliminar de acção de condenação da Reqda. SIOUX PHARM INC., nos

mesmos termos do pedido ora formulado, de cuja propositura a Reqte., SUMMIT NUTRITIONALS

INTERNATIONAL INC., desde já requer dispensa no pressuposto de a matéria a adquirir neste procedimento

permitir formar convicção segura acerca da existência do direito acautelado, sendo a providência a decretar

adequada a realizar a composição definitiva do litígio.

Google Docs

https://drive.google.com/file/d/0BxwrutfOyLhCTG42SE1aV1VncDg/view?usp=sharing

https://drive.google.com/file/d/0BxwrutfOyLhCOWtjV0NfZjhhNUE/view?usp=sharing

https://drive.google.com/file/d/0BxwrutfOyLhCNzlyRFNfRG10T2c/view?usp=sharing

https://drive.google.com/file/d/0BxwrutfOyLhCamtXNG1MZE5HXzQ/view?usp=sharing

https://drive.google.com/file/d/0BxwrutfOyLhCbmhJODJMUFpMY1k/view?usp=sharing

View full review
Reason of review:
Not as described/ advertised

Preferred solution: Let the company propose a solution

1 comment
Elvis Oeb

Summit Nutritionals International, Inc of New Jersey is victorious in their legal battle against Sioux Pharm, Inc of Sioux Center, Iowa. As of October 2, 2015, Dr.

Allan Kramer, President of Sioux Pharm, Inc, has formally withdrawn all claims made against Summit Nutritionals International in Case No. LACV 023704 in the Distict Court in and for Woodbury County, Iowa.

In addition, Sioux Pharm retracts all allegations made against Summit Nutritionals International.

For more information regarding the recent victory of Summit Nutritionals against Sioux Pharm, please visit the following links.

https://youtu.be/3s2_LdrkHzE

https://www.youtube.com/watch?v=HiNmCtBkvOc

https://drive.google.com/open?id=0Bw_vbILKB2esbXRYMnJfT0dQOTA http://summitnutritionals.com/sioux-pharm-inc-withdrawal-of-claims-and-retraction-of-allegations-against-summit-nutritionals-international-inc/ http://summitnutritionals.net/sioux-pharm-inc-withdrawal-of-claims-and-retraction-of-allegations-against-summit-nutritionals-international-inc/ http://americanchondroitin.com/sioux-pharm-inc-withdrawal-of-claims-and-retraction-of-allegations-against-summit-nutritionals-international-inc/ http://usachondroitin.com/sioux-pharm-inc-withdrawal-of-claims-and-retraction-of-allegations-against-summit-nutritionals-international-inc/ http://summitnutritionalsinc.com/sioux-pharm-inc-withdrawal-of-claims-and-retraction-of-allegations-against-summit-nutritionals-international-inc/ http://droi-kon.com/sioux-pharm-inc-withdrawal-of-claims-and-retraction-of-allegations-against-summit-nutritionals-international-inc/ http://sioux-pharm-inc-and-sioux-pharm-biochemical.pissedconsumer.com/summit-nutritionals-vs-sioux-pharm-inc-withdrawal-of-claims-and-retraction-of-allegations-201510****3890.html http://www.scam.com/showthread.php?685246-Summit-Nutritionals-International-vs-Sioux-Pharm-Inc-Withdrawal-of-Claims-and-Retraction-of-Allegations&p=188****#post188**** https://summitnutritionals.wordpress.com

Elvis Oeb

This review is from a real person who provided valid contact information and hasn't been caught misusing, spamming or abusing our website. Check our FAQ

Verified Reviewer

Summit Nutritionals International vs. Sioux Pharm,Inc. - Sioux Falls, IA

stars-rating-full stars-rating-full stars-rating-full stars-rating-full stars-rating-full

To The Honorable Judge of

the Lisbon District Court

SUMMIT NUTRITIONAL INTERNATIONAL

INC., branch in Portugal, Juristic Person

Number 98041****, with its domicile in

Lisbon, at Empreendimento Nova

Amoreiras – Palácio- 3ºpiso, secção 9, Rua

Artilharia 1, 71-77, 125*-038 Lisboa,

Portugal

Hereby commences non-typified interlocutory

injunction proceedings against,

SIOUX PHARM INC., an American company

with its registered office in 121 19th Street SW

Sioux Center, IA 51250, Iowa, United States of America

in the following terms and on the following

grounds,

1

The Applicant, SUMMIT NUTRITIONALS INTERNATIONAL INC., is a

commercial company, with its registered office in New Jersey, USA, which, via

its branch in Portugal, is in the business of the commercialization in the

European Union of chondroitine sulphate with the brand name DROI-KON,

which it imports from the USA.

2

The product commercialized by the Applicant, SUMMIT NUTRITIONALS

INTERNATIONAL INC., is food grade chondroitine sulphate, which is subject to

a purity requirement that it must contain not less than 90% of chondroitine

sulphate. There is also pharmaceutical grade chondroitine sulphate on the

market, which must not only have the same minimum chondroitine sulphate

content, but is also required to comply with certain requirements of the USP

(USA Pharmacopeia). As clarified in the information attached as document no.1.

which contents are incorporated by this reference.

3

The Applicant, SUMMIT NUTRITIONALS INTERNATIONAL INC., habitually

acquires the product it commercializes from the manufacturer EAGLE

LABORATORIES INC., whose plant is located in the State of IOWA in the USA.

4

The Respondent, SIOUX PHARM INC., is a commercial company with its

registered office in the said state of IOWA, which is in the business of the

manufacture and commercialization of pharmaceutical grade chondroitine

sulphate under the CHONDROPURE brand name, among other products.

5

Food grade chondroitine sulphate is commercialized in Europe at a price

between twenty and thirty euro/kilo, while the price of the pharmaceutical grade

product is more than one hundred euro/kilo.

6

The product commercialized by the Applicant, SUMMIT NUTRITIONALS

INTERNATIONAL INC., is submitted by it for analysis by laboratories accredited

by the FDA - Food and Drug Administration in the USA, and these analyses

have always shown the existence of at least 90% of chondroitine sulphate in the

samples, i.e., the product’s required purity level. Certificate of analysis, and

reports of 5 analysis referred in this certificate, are attached as document no.2

to 7, which contents are incorporated by this reference.

7

The Applicant’s clients in Europe, of which there are more than twenty, also

conduct analyses of samples of the product supplied by the Applicant SUMMIT

NUTRITIONALS INTERNATIONAL INC., at laboratories selected by them. As at

the date hereof, none of the said clients have complained regarding the purity of

the product and they have always expressed their total satisfaction with the

quality of the product supplied by the Applicant, SUMMIT NUTRITIONALS

INTERNATIONAL INC.

8

It is important to highlight that the Applicant, SUMMIT NUTRITIONALS

INTERNATIONAL INC., acquired from the extremely demanding “Better

Business Bureau Serving New Jersey”, the accreditation as a company that

uses business practices according to ethics in advertisement, in sales and in

commercial relationships with clients, as displayed in the certificate attached as

document no.8, which contents are incorporated by this reference.

9

It is noteworthy that the methods of analysis appropriate to the analysis of the

food grade product differ from those appropriate to the analysis of the

pharmaceutical grade product. Furthermore, if analysis methods appropriate to

the analysis of the pharmaceutical grade product are used to analyze the food

grade product, the results obtained can show a purity level which is less than

the required level.

10

In an industrial and commercial dispute with the Applicant's said supplier, the

Respondent, SIOUX PHARM INC., commenced legal proceedings in IOWA in

which it complains of acts of industrial espionage and of the adulteration of

chondroitine sulphate by EAGLE LABORATORIES INC., via the addition of

maltodextrin.

11

The Respondent, SIOUX PHARM INC., also claims in the said legal

proceedings that the Applicant, SUMMIT NUTRITIONALS INTERNATIONAL

INC., and another company, which is also a client of Eagle Laboratories,

together with latter have diluted chondroitine sulphate with maltodextrin. This

claim is manifestly untrue as the Respondent, SIOUX PHARM INC., is well

aware that the Applicant, SUMMIT NUTRITIONALS INTERNATIONAL INC., is

not a manufacturer and that it merely commercializes the product it acquires

from manufacturers.

12

The Applicant, SUMMIT NUTRITIONALS INTERNATIONAL INC., has no

reason to believe that its supplier EAGLE LABORATORIES INC. adulterates

the product, but can assert that even if its said supplier is guilty of the said

conduct, there is no adulteration of the product supplied to the Applicant,

SUMMIT NUTRITIONALS INTERNATIONAL INC., as is clear from the analyses

systematically carried out by both the Applicant, SUMMIT NUTRITIONALS

INTERNATIONAL INC., and its clients.

13

On the false assumption that the Applicant, SUMMIT NUTRITIONALS

INTERNATIONAL INC., commercialized an adulterated product and that it has

contributed to the said adulteration, the Respondent, SIOUX PHARM INC.,

accuses the Applicant, SUMMIT NUTRITIONALS INTERNATIONAL INC., of

unfair competition and seeks that damages be awarded against the Applicant,

SUMMIT NUTRITIONALS INTERNATIONAL INC., with regard to the loss and

damage suffered by the Respondent, SIOUX PHARM INC., which loss and

damage it neither specifies not quantifies, and that the Applicant, SUMMIT

NUTRITIONALS INTERNATIONAL INC., be freezed from diluting chondroitine

sulphate and from distributing or selling diluted chondroitine sulphate, and

further that the Applicant’s business in competition with the Respondent, SIOUX PHARM INC., be restrained or suspended at least while the proceedings are

pending, which latter claim is manifestly excessive in the light of the facts

pleaded.

14

The Respondent’s latter claim is a clear illustration of its real objective, which is

to achieve a monopoly, or quasi-monopoly, in the market for the product in

question, reduced to pharmaceutical grade, which is something that a remedy,

which is merely corollary to the facts pleaded, i.e. that the Applicant, SUMMIT

NUTRITIONALS INTERNATIONAL INC., be restrained from commercializing

the adulterated product, would not permit it to achieve.

15

Given the fact that the Respondent, SIOUX PHARM INC., also commercializes

its product in the EU, the Applicant, SUMMIT NUTRITIONALS

INTERNATIONAL INC., has good reason to fear that the Respondent, SIOUX PHARM INC., which also has clients in this market, will seek to perturb the

activity of the Applicant’s branch in Portugal, via false statements intended to

discredit it, i.e. false descriptions of the quality of the product commercialized by

the Applicant, SUMMIT NUTRITIONALS INTERNATIONAL INC., which

amounts to anti-competitive conduct that is contrary to the honest custom and

practice in any economic activity.

16

Given the great difference between the price of the product commercialized by

the Respondent, SIOUX PHARM INC., and the product commercialized by the

Applicant, SUMMIT NUTRITIONALS INTERNATIONAL INC., it is easy to

comprehend the Respondent’s, SIOUX PHARM INC., interest in discrediting the

Applicant, SUMMIT NUTRITIONALS INTERNATIONAL INC., or even in

eliminating companies from the market that supply a market segment with a

much lower prices, which will only have recourse to the Respondent’s, SIOUX PHARM INC., product, when the uses of the product or the requirements of the

end clients cannot at all be satisfied by the food grade product.

17

Furthermore, the Respondent’s, SIOUX PHARM INC., conduct is not limited to

this unfair competition, to which it has already had recourse in the legal

proceedings in IOWA. The Respondent’s, SIOUX PHARM INC., greed is such

that it adulterates its own product in order to increase its profits, not only by

increasing its sales through the elimination of the Applicant, SUMMIT

NUTRITIONALS INTERNATIONAL INC., from the market but also by reducing

its production costs by adulteration of the product.

18

The adulteration of the Respondent’s, SIOUX PHARM INC., product, for which

only the Respondent, SIOUX PHARM INC., can be responsible, was noted by

the Applicant, SUMMIT NUTRITIONALS INTERNATIONAL INC., via an

analysis of the contents of a package clearly identified as Chondropure,

supplied by the Respondent, SIOUX PHARM INC..

19

This package was supplied by the Respondent, SIOUX PHARM INC., to a

company that is also a food grade client of the Applicant, SUMMIT

NUTRITIONALS INTERNATIONAL INC., and was made available by the said

company for analysis by the Applicant, SUMMIT NUTRITIONALS

INTERNATIONAL INC.

20

The analysis of the said product by an independent laboratory approved by the

FDA, showed that the product supplied by the Respondent, SIOUX PHARM INC., does not even comply with the requirements applicable to the food grade

product, as the chondroitine content of the product was only 24.90% and also

does not comply with other requirements applicable to the pharmaceutical

grade product, as result from the analysis report from the 4th March 2015, and

from the identification of the analyzed sample, which are attached as

documents no. 9 and no. 10 which contents are incorporated by reference.

21

By selling the said non-compliant product that lacks the required characteristics

and does not meet the expectations of the Respondent’s, SIOUX PHARM INC.,

clients and lacks the characteristics announced by the Respondent, SIOUX PHARM INC., it is also guilty of unfair competition on the grounds of false

description or incorrect indication of the product’s quality and use.

22

The Applicant, SUMMIT NUTRITIONALS INTERNATIONAL INC., is entitled to

carry on its lawful and transparent economic activity in the European market in

fair competition with the other operators in this market and to be protected from

perturbations caused by operators that act in violation of the honest practices of

this business.

23

The Respondent’s, SIOUX PHARM INC., stigmatized conduct causes the

Applicant, SUMMIT NUTRITIONALS INTERNATIONAL INC., to fear that it will

apply them in order to wrongfully interfere with and perturb its business in the

European market.

24

The Applicant’s fear is amply justified by the Respondent’s, SIOUX PHARM INC., said conduct and fully justifies the grant of appropriate interlocutory

injunctions in order to protect the Applicant’s threatened right.

25

In this case, the interlocutory injunctions sought are that the Respondent,

SIOUX PHARM INC., be restrained from making any statements likely to

discredit the Applicant, SUMMIT NUTRITIONALS INTERNATIONAL INC., and

its product and that it be further restrained from introducing chondroitine

sulphate into the European market that does not comply fully with the purity

requirement of at least 90% of this product and that, in the case of

pharmaceutical grade chondroitine sulphate, which does not comply with the

other requirements applicable to that grade of product.

26

The risk of harm that the Applicant, SUMMIT NUTRITIONALS

INTERNATIONAL INC., seeks to prevent is the risk that the Respondent,

SIOUX PHARM INC., will cause irreparable harm, or harm that is difficult to

remedy, to it, by affecting its reputation for honesty and the reputation of its

product, by raising doubts as to the purity thereof, and that this will have an

inevitable effect on the Applicant’s clients and is likely to result in a drastic

reduction of its sales and in its replacement by competitors, which it would

subsequently be difficult, if not impossible, to dislodge.

27

The said risk is not specifically provided for in any of the interlocutory injunctions

typified in the law.

28

It is important to refer, due to the predictable behavior of the Respondent,

SIOUX PHARM INC., not granting the protective order, matters to the Applicant,

SUMMIT NUTRITIONALS INTERNATIONAL INC, who has always showed in its

behavior transparency, strictness and the following the rules and honest

practices of the branch of the commercial activity they are inserted, enormous

damages, leading to a sales reduction and damaging its credibility in the market.

29

On another hand, from the granting of the protective order, which will not be

more than demanding from the Respondent, SIOUX PHARM INC., acts

accordingly to the honest practices of the practiced activity, mainly by avoiding

the adulteration of the commercialized product, no damage, obviously can result

to the Respondent, SIOUX PHARM INC.

Accordingly and on such other

grounds as this Honorable Court

finds on its own motion, the

Respondent, SIOUX PHARM INC.,

should be restrained from

making any statements likely to

discredit the Applicant, SUMMIT

NUTRITIONALS

INTERNATIONAL INC., and its

product and be further restrained

from introducing Chondroitine

Sulphate into the European

market that does not comply fully

with the purity requirement of at

least 90% of this product and, in

the case of pharmaceutical

grade chondroitine sulphate,

which does not comply with the

other requirements applicable to

that grade of product.

The Applicant requests that this

petition is served to the

Defendant in the terms of the

Hague Convention 15 November

1965 in order for the Defendant

to oppose to this petition within

the legal delay.

This protective order is requested as a preliminary to the action of

condemnation of the Respondent, SIOUX PHARM INC; in the same terms

requested in this petition.

Evidence:

Witness: Ana Santos, married, manager, with address at Empreendimento Nova

Amoreiras, Palácio – 3º Piso/Secção 9 Rua Artilharia 1, 71-77, 125*-038

Lisboa, Portugal

The attorney

Henrique Abecasis

View full review
Reason of review:
Bad quality

Preferred solution: Let the company propose a solution

3 comments
Elvis Oeb

Summit Nutritionals International, Inc of New Jersey is victorious in their legal battle against Sioux Pharm, Inc of Sioux Center, Iowa. As of October 2, 2015, Dr.

Allan Kramer, President of Sioux Pharm, Inc, has formally withdrawn all claims made against Summit Nutritionals International in Case No. LACV 023704 in the Distict Court in and for Woodbury County, Iowa.

In addition, Sioux Pharm retracts all allegations made against Summit Nutritionals International.

For more information regarding the recent victory of Summit Nutritionals against Sioux Pharm, please visit the following links.

https://youtu.be/3s2_LdrkHzE

https://www.youtube.com/watch?v=HiNmCtBkvOc

https://drive.google.com/open?id=0Bw_vbILKB2esbXRYMnJfT0dQOTA http://summitnutritionals.com/sioux-pharm-inc-withdrawal-of-claims-and-retraction-of-allegations-against-summit-nutritionals-international-inc/ http://summitnutritionals.net/sioux-pharm-inc-withdrawal-of-claims-and-retraction-of-allegations-against-summit-nutritionals-international-inc/ http://americanchondroitin.com/sioux-pharm-inc-withdrawal-of-claims-and-retraction-of-allegations-against-summit-nutritionals-international-inc/ http://usachondroitin.com/sioux-pharm-inc-withdrawal-of-claims-and-retraction-of-allegations-against-summit-nutritionals-international-inc/ http://summitnutritionalsinc.com/sioux-pharm-inc-withdrawal-of-claims-and-retraction-of-allegations-against-summit-nutritionals-international-inc/ http://droi-kon.com/sioux-pharm-inc-withdrawal-of-claims-and-retraction-of-allegations-against-summit-nutritionals-international-inc/ http://sioux-pharm-inc-and-sioux-pharm-biochemical.pissedconsumer.com/summit-nutritionals-vs-sioux-pharm-inc-withdrawal-of-claims-and-retraction-of-allegations-201510****3890.html http://www.scam.com/showthread.php?685246-Summit-Nutritionals-International-vs-Sioux-Pharm-Inc-Withdrawal-of-Claims-and-Retraction-of-Allegations&p=188****#post188**** https://summitnutritionals.wordpress.com

Guest

There isn't a town in Iowa named Sioux Falls. Study your geography.

Elvis Oeb

Sioux Pharm - Sioux Falls, Iowa - False Claims of Chondroitin Sulfate Purity

View more comments (2)

Why Trust Reviews on PissedConsumer?

  • Professional auto and live moderation
  • 100% user-generated content
  • Equal opportunity and protection
  • Zero tolerance for fake reviews
  • Verified content
  • PissedConsumer is on the Inc. 5000 list

For more information read Blog article